🎁 Black Friday: up to 50% off of annual plans
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
5.57
-0.29 (-4.95%)
At close: Nov 20, 2026, 4:00 PM EST
5.60
+0.03 (0.54%)
After-hours: Nov 20, 2026, 7:30 PM EST

Ocular Therapeutix Revenue

Ocular Therapeutix had revenue of $12.87M in the quarter ending September 30, 2026, a decrease of -11.48%. This brings the company's total for the last twelve months to $50.38M, down -9.68% year-over-year. In the year 2025, Ocular Therapeutix had annual revenue of $51.95M, down -18.47%. That makes Ocular Therapeutix the 27,981st largest company in the world by revenue and 3,770th in the United States.

Revenue (ttm)
$50.38M
Revenue Growth
-9.68%
P/S Ratio
24.32
Revenue / Employee
$155,028
Employees
325
Market Cap
1.23B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202551.95M-11.77M-18.47%
Dec 31, 202463.72M5.28M9.03%
Dec 31, 202358.44M6.95M13.49%
Dec 31, 202251.49M7.97M18.32%
Dec 31, 202143.52M26.12M150.08%
Dec 31, 202017.40M13.18M311.71%
Dec 31, 20194.23M2.24M112.41%
Dec 31, 20181.99M67.00K3.48%
Dec 31, 20171.92M36.00K1.91%
Dec 31, 20161.89M137.00K7.83%
Dec 31, 20151.75M978.00K126.68%
Dec 31, 2014772.00K--
Dec 31, 2013---
Dec 31, 201210.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MannKind413.37M
Novavax411.65M
Generate Biomedicines21.07M
Taysha Gene Therapies5.49M
Absci1.49M
Silence Therapeutics456.00K
Revenue Rankings